01.10
PharmaNet Development Group Retains JFK
Communications
Leading Global Clinical Research
Organization Taps JFK for Strategic Communications Programs
Princeton, NJ, January 6, 2010 — JFK Communications, Inc. announced
today that the firm has added a new client, PharmaNet Development Group, Inc. (www.pharmanet.com) of Princeton, NJ, to its
growing client portfolio. JFK Communications will provide support on a variety
of services designed to increase awareness of PharmaNet as a world leader in
clinical research services.
“Our
extensive pharmaceutical and medical technology experience makes us an ideal
partner for PharmaNet,” said David Avitabile, President, JFK communications,
Inc. “Clinical research organizations
provide an invaluable service to the life sciences industry, and we are
thrilled to be chosen as a marketing communications partner by such a
prestigious group as PharmaNet.”
JFK
welcomes PharmaNet to its expanding client roster, which includes GE
Healthcare, TopoTarget, NicOx, Novo Nordisk, and Taiho Pharmaceuticals, among
others.
JFK Communications, Inc. provides innovative public
relations solutions for the pharmaceutical, biotechnology and medical
technology industries. For more information on JFK Communications’
capabilities or career opportunities, please visit the JFK Web site at www.jfkhealth.com, or call us at (609) 514-5117.
###